Biguanides
发表于 2025-3-23 13:20:52
http://reply.papertrans.cn/89/8822/882179/882179_11.png
FLORA
发表于 2025-3-23 17:25:42
http://reply.papertrans.cn/89/8822/882179/882179_12.png
STRIA
发表于 2025-3-23 22:02:29
http://reply.papertrans.cn/89/8822/882179/882179_13.png
外貌
发表于 2025-3-24 00:59:37
http://reply.papertrans.cn/89/8822/882179/882179_14.png
变量
发表于 2025-3-24 03:02:01
http://reply.papertrans.cn/89/8822/882179/882179_15.png
为宠爱
发表于 2025-3-24 10:36:00
Oral Mucositis,mple of other agents in development for which efficacy is based on disruption of the biological pathways leading to mucositis. This chapter discusses the clinical characteristics of mucositis, how it is evaluated and scored, its pathogenesis, and current and evolving prevention and treatment strategies.
DEMN
发表于 2025-3-24 11:34:41
Neutropenia,the current guidelines for use. Lastly, while the focus will be predominantly around support for chemotherapy-induced neutropenia, the impact of myeloid growth factors in other settings, including high-dose chemotherapy and the management of chronic neutropenia will also be briefly addressed.
AGGER
发表于 2025-3-24 15:36:38
Book 20091st editionlated to the cancer and/or its treatment; physical, psychosocial and emotional issues associated with the cancer. Patients with cancer, in general, are living longer. Even those with advanced, metastatic disease have an increase in their survival. This, in part, is due to better therapies, novel tre
无法治愈
发表于 2025-3-24 21:41:54
Management of Dyspnea, in the context of a patient’s goals of care. Although invasive and pharmacologic interventions can be useful in many patients, because dyspnea is a subjective phenomenon, psychosocial/spiritual support is needed in all patients.
手术刀
发表于 2025-3-25 00:19:25
Pathogenesis and Management of Venous Thromboembolism in Cancer Patients,) The epidemiology of VTE in cancer patients, (2) The pathogenesis of cancer-related thrombosis, (3) The prevention and treatment of VTE in the cancer patient, and (4) Special topics in VTE management including management of recurrent VTE and heparin-induced thrombocytopenia.